Potential hypoglycemic effect of an ethanol extract of Gynostemma pentaphyllum in C57BL/KsJ-db/db mice

Journal of Medicinal Food

Volumn 11, Issue 4, 2008, Pages 709-716

  Yeo, Jiyoung ^a   Kang, Young Jin ^a   Jeon, Seon Min ^a   Jung, Un Ju ^b   Lee, Mi Kyung ^c   Song, Hebok ^a   Choi, Myung Sook ^a  

^a Kyungpook National University   (South Korea)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c Sunchon National University   (South Korea)

Author keywords

Blood glucose lowering; C57BL KsJ db db mice; Gypenosides; Type 2 diabetes

Indexed keywords

ALCOHOL; GLUCOKINASE; GLUCOSE; GLUCOSE 6 PHOSPHATASE; GYNOSTEMMA PENTAPHYLLUM EXTRACT; GYPENOSIDE; INSULIN; ROSIGLITAZONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; C57BL MOUSE; CONTROL GROUP; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG ACTIVITY; DRUG MEGADOSE; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; HISTOLOGY; HYPOGLYCEMIC EFFECT; INSULIN BLOOD LEVEL; INSULIN METABOLISM; INSULIN TOLERANCE TEST; LIVER METABOLISM; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; PANCREAS ISLET; PLANT LEAF; PRIORITY JOURNAL;

ANIMALS; BLOOD GLUCOSE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOKINASE; GLUCOSE TOLERANCE TEST; GLUCOSE-6-PHOSPHATASE; GYNOSTEMMA; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; IMMUNOHISTOCHEMISTRY; INSULIN; INSULIN-SECRETING CELLS; LIVER; MALE; MICE; MICE, INBRED C57BL; PANCREAS; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES; THIAZOLIDINEDIONES;

ANIMALIA; GYNOSTEMMA PENTAPHYLLUM; MUS;

EID: 57349083738     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2007.0148     Document Type: Article

References (49)

1. Rosenbloom AL, Joe JR, Young RS, Winter WE: Emerging epidemic of type 2 diabetes in youth. Diabetes Care 1999;22:345-354.
2. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986.
3. DeFronzo RA: Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med 1999;131:281-303.
4. Gaster B, Hirsch IB: The effects of improved glycemic control on complications in type 2 diabetes. Arch Intern Med 1998;158:134-140.
5. Attele AS, Zhou YP, Xie JT, Wu JA, Zhang L, Dey L, Pugh W, Paul AR, Polonsky KS, Yuan CS: Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes 2002;51:1851-1858.
6. Xie JT, Aung HH, Wu JA, Attele AS, Yuan CS: Effects of American ginseng berry extract on blood glucose levels in ob/ob mice. Am J Chin Med 2002;30:187-194.
7. Xie JT, Zhou YP, Dey L, Attele AS, Wu JA, Gu M, Polonsky KS, Yuan CS: Ginseng berry reduces blood glucose and body weight in db/db mice. Phytomedicine 2002;9:254-258.
8. Ackerknecht EH: A Short History of Medicine. Johns Hopkins University Press, Baltimore, 1982.
9. Anhäuser M: Pharmacists seek the solution of a shaman. Drug Discov Today 2003;8:868-869.
10. Atta Ur R, Zaman K: Medicinal plants with hypoglycemic activity. J Ethnopharmacol 1989;26:1-55.
11. Li L, Jiao L, Lau BH: Protective effect of gypenosides against oxidative stress in phagocytes, vascular endothelial cells, and liver microsomes. Cancer Biother 1993;8:263-272.
12. Lin JM, Lin CC, Chiu HF, Yang JJ, Lee SG: Evaluation of the anti-inflammatory and liver-protective effects of Anoectochilus formosanus, Ganoderma lucidum and Gynostemma pentaphyllum in rats. Am J Chin Med 1993;21:59-69.
13. Jang YJ, Kim JK, Lee MS, Ham IH, Whang WK, Kim KH, Kim HJ: Hypoglycemic and hypolipidemic effects of crude saponin fractions from Panax ginseng and Gynostemma pentaphyllum. Yakhak Hoechi 2001;45:545-556.
14. Zhou Z, Wang Y, Zhou Y, Zhang S: Effect of Gynostemma pentaphyllum Mak on carcinomatous conversions of golden hamster cheek pouches induced by dimethylbenzanthracene: a histological study. Chin Med J (Engl Ed) 1998;111:847-850.
15. Kuwahara M, Kawanishi F, Komiya T, Ohshio H: Alkaline cleavage of gypenosides and characterization of dammarane-type aglycones by gas chromatography-mass spectrometry. Chem Pharm Bull 1989;37:135-139.
16. Takemoto T, Arihara S, Nakajima T, Okuhara M: Studies on the constituents of Gynostemma pentaphyllum Makino. Structures of gypenoside I-XIV. Yakugaku Zasshi 1983;103:173-185.
17. Attele AS, Zhou YP, Xie JT, Wu JA, Zhang L, Dey L, Pugh W, Rue PA, Polonsky KS, Yuan CS: Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes 2002;51:1851-1858.
18. Norberg A, Hoa NK, Liepinsh E, Van Phan D, Thuan ND, Jörnvall H, Sillard R, Ostenson CG: A novel insulin-releasing substance, Phanoside, from the plant Gynostemma pentaphyllum. J Biol Chem 2004;279:41361-41367.
19. American Institute of Nutrition: Report of the American Institute of Nutrition ad hoc Committee on Standards for Nutritional Studies. J Nutr 1977;107:1340-1348.
20. American Institute of Nutrition: Report of Ad Hoc Committee on Standards for Nutritional Studies. J Nutr 1980;110:1717-1726.
21. Chen JC, Tsai CC, Chen LD, Chen HH, Wang WC: Therapeutic effect of gypenoside on chronic liver injury and fibrosis induced by CCl4 in rats. Am J Chin Med 2000;28:175-185.
22. Cui JF, Eneroth P, Bruhn JG: Gynostemma pentaphyllum: identification of major sapogenins and differentiation from Panax species. Eur J Pharm Sci 1999;8:187-191.
23. Attawish A, Chivapat S, Phadungpat S, Bansiddhi J, Techadamrongsin Y, Mitrijit O, Chaorai B, Chavalittumrong P: Chronic toxicity of Gynostemma pentaphyllum. Fitoterapia 2004;75:539-551.
24. Lipschitz DA, Cook JD, Finch CA: A clinical evaluation of serum ferritin as an index of iron stores. N Engl J Med 1974;290:1213-1216.
25. Drysdale JW: Ferritin phenotypes: structure and metabolism. Ciba Found Symp 1976;51:41-67.
26. Gorogawa S, Kajimoto Y, Umayahara Y, Kaneto H, Watada H, Kuroda A, Kawamori D, Yasuda T, Matsuhisa M, Yamasaki Y, Hori M: Probucol preserves pancreatic β-cell function through reduction of oxidative stress in type 2 diabetes. Diabetes Res Clin Pract 2002;57:1-10.
27. Hulcher FH, Oleson WH: Simplified spectrophotometric assay for microsomal 3-hydroxy-3-methylglutaryl CoA reductase by measurement of coenzyme A. J Lipid Res 1973;14:625-631.
28. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
29. Bentle LA, Lardy HA: Interaction of anions and divalent metal ions with phosphopyruvate carboxykinase. J Biol Chem 1976;251:2916-2921.
30. Alegre M, Ciudad CJ, Fillat C, Gulnovant JJ: Determination of glucose-6-phosphatase activity using the glucose dehydrogenase-coupled reaction. Anal Biochem 1988;173:185-189.
31. Davidson AL, Arion WJ: Factors underlying significant underestimations of glucokinase activity in crude liver extracts: physiological implications of higher cellular activity. Arch Biochem Biophys 1987;253:156-167.
32. Seifter S, Dayton S, Novic B, Muntwyler E: The estimation of glycogen with the anthrone reagent. Arch Biochem Biophys 1950;50:191-200.
33. Fujiwara T, Wada M, Fukuda K, Fukami M, Yoshioka S, Yoshioka T, Horikoshi H: Characterization of CS-045, a new oral antidiabetic agent: II. Effects on glycemic control and pancreatic islet structure at a late stage of the diabetic syndrome in C57BL/KsJ-db/db mice. Metabolism 1991;40:1213-1218.
34. Cavaghan MK, Ehrmann DA, Polonsky KS: Interactions between insulin resistance and insulin secretion in the development of glucose intolerance. J Clin Invest 2000;106:329-333.
35. Park SA, Choi MS, Kim MJ, Jung UJ, Kim HJ, Park KK, Noh HJ, Park HM, Park YB, Lee JS, Lee MK: Hypoglycemic and hypolipidemic action of Du-zhong (Eucommia ulmoides Oliver) leaves water extract in C57BL/KsJ-db/db mice. J Ethnopharmacol 2006;107:412-417.
36. Saltiel AR, Olefsky JM: Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes 1996;45:1661-1669.
37. Malinowski JM, Bolesta S: Rosiglitazone in the treatment of type 2 diabetes mellitus: a critical review. Clin Ther 2000;22:1151-1168.
38. Young PW, Buckle DR, Cantello BC, Chapman H, Clapham JC, Coyle PJ, Haigh D, Hindley RM, Holder JC, Kallender H, Latter AJ, Lawrie KW, Mossakowska D, Murphy GJ, Roxbee Cox L, Smith SA: Identification of high-affinity binding sites for the insulin sensitizer rosiglitazone (BRL-49653) in rodent and human adipocytes using a radioiodinated ligand for peroxisomal proliferators-activated receptor gamma. J Pharmacol Exp Ther 1988;284:751-759.
39. Spiegelman BM: PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. Diabetes 1988;47:507-514.
40. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA: An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem 1995;270:12953-12956.
41. American Diabetes Association: Consensus Development Conference on Insulin Resistance. Diabetes Care 1998;21:310-314.
42. Watkins SM, Reifsnyder PR, Pan HJ, German JB, Leiter EH: Lipid metabolism-wide effects of the PPARgamma agonist rosiglitazone. J Lipid Res 2002;43:1809-1817.
43. nd ed. Lippincott Williams & Wilkins, Philadelphia, 2000, pp. 963-977.
44. Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, Nagaretani H, Matsuda M, Komuro R, Ouchi N, Kuriyama H, Hotta K, Nakamura T, Shimomura I, Matsuzawa Y: PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 2001;50:2094-2099.
45. Postic C, Shiota M, Niswender KD, Jetton TL, Chen Y, Moates JM, Shelton KD, Lindner J, Cherrington AD, Magnuson MA: Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J Biol Chem 1999;274:305-315.
46. Ferre T, Pujol A, Riu E, Bosch F, Valera A: Correction of diabetic alterations by glucokinase. Proc Natl Acad Sci U S A 1996;93:7225-7230.
47. Iynedjian PB, Gjinovci A, Renold AE: Stimulation by insulin of glucokinase gene transcription in liver of diabetic rats. J Biol Chem 1988;263:740-744.
48. Cour B, Molgaard P, Yi Z: Traditional Chinese medicine in treatment of hyperlipidaemia. J Ethnopharmacol 1995;46:125-129.
49. Wang QF, Chen JC, Hsieh SJ, Cheng CC, Hsu SL: Regulation of Bcl-2 family molecules and activation of caspase cascade involved in gypenosides-induced apoptosis in human hepatoma cells. Cancer Lett 2002;183:169-178.